Basic Info
  • Grade: pharmaceutical grade

    Factory Location: Shanghai

    Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Eastern Europe,Australasia,Asia,Middle East,Africa

  • Sample Provided: no

    Venetola is an oral biologic that is a selective small molecule inhibitor of the anti apoptotic protein Bcl-2 and has potential anti-tumor activity. Venetola simulates the BH3 only protein, which is the native ligand and apoptosis activator of Bcl-2. By binding to the hydrophobic groove of Bcl-2 protein, it inhibits the activity of Bcl-2 and restores the apoptosis process of tumor cells. Bcl-2 protein is overexpressed in some cancers and plays an important role in regulating cell apoptosis; Its expression is related to the increase of drug resistance and tumor cell survival rate. Compared with the Bcl-2 inhibitor navitoclax, this drug does not inhibit bcl-XL and does not cause bcl-XL mediated thrombocytopenia.
Send your message to this supplier
  • From:
  • To:
    Shanghai Hope-chem Co.,Ltd.
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service